MEI PHARMA INC (MEIP)
US55279B3015 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 19.84M | -31.84M | -54.45M | -41.31M | -47.17M | |||
| Depreciation Amortization | 372.00K | 390.00K | 330.00K | 290.00K | 110.00K | |||
| Change In Working Capital | -77.60M | -24.95M | 16.88M | 16.94M | 51.42M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | 0.00 | 10.00K | 0.00 | |||
| Other non cash items | 4.41M | 3.92M | -11.49M | -7.88M | 29.90M | |||
| OPERATING CASH FLOW | -52.98M | -52.48M | -48.75M | -31.96M | 34.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -40.00K | -480.00K | -710.00K | -890.00K | |||
| Other Investing Activity | 58.94M | 53.73M | 7.37M | 25.42M | -105.40M | |||
| INVESTING CASH FLOW | 58.89M | 53.69M | 6.89M | 24.71M | -106.29M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 0.00 | 52.90M | 3.47M | 69.50M | |||
| Other Financing Activity | 0.00 | -40.00K | -3.85M | 0.00 | 5.27M | |||
| FINANCING CASH FLOW | -11.66M | -40.00K | 49.05M | 3.47M | 74.78M | |||
| CHANGE IN CASH | -5.74M | 1.17M | 7.19M | -3.78M | 2.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -52.98M | -52.48M | -48.75M | -31.96M | 34.26M | |||
| Capital Expenditure | N/A | -40.00K | -480.00K | -710.00K | -890.00K | |||
| FREE CASH FLOW | -53.02M | -52.52M | -49.23M | -32.67M | 33.37M | |||
All data in USD